Factors associated with receipt of mRNA-1273 vaccine at a United States national retail pharmacy during the COVID-19 pandemic

CONCLUSION: Over 80% of patients received their on-time second dose of mRNA-1273 vaccine per CDC recommendations. Patient demographics and community characteristics were associated with vaccine receipt and series completion. Novel approaches to facilitate series completion during a pandemic should be further studied.PMID:37296016 | PMC:PMC10172969 | DOI:10.1016/j.vaccine.2023.03.076
Source: Vaccine - Category: Allergy & Immunology Authors: Source Type: research